Rižner TL

No ORCID on file · 31 papers in corpus
lab-animal 2011
Chemico-biological interactions ·doi:10.1016/j.cbi.2011.01.002

Human 17β-hydroxysteroid dehydrogenase (17β-HSD) type 1 is an enzyme that acts at the pre-receptor level. It catalyzes the NADPH-dependent reduction of the weak estrogen estrone into the most potent estrogen 17β-estradiol, which exerts prol…

lab-animal 2011
Hormone molecular biology and clinical investigation ·doi:10.1515/HMBCI.2011.012

BACKGROUND: Human 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) acts at a pre-receptor level. It catalyzes NADPH-dependent reduction of the weak estrogen estrone into the most potent estrogen estradiol, which exerts its proliferative e…

review 2011
Current medicinal chemistry ·doi:10.2174/092986711795933713

The AKR1C aldo-keto reductases (AKR1C1-AKR1C4) are enzymes that interconvert steroidal hormones between their active and inactive forms. In this manner, they can regulate the occupancy and trans-activation of the androgen, estrogen and prog…

other 2011
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2011.03.010

In the search for novel biomarkers of endometriosis, we selected 152 genes from the GeneLogic database based on results of genome-wide expression analysis of ovarian endometriosis, plus 20 genes related to estrogen metabolism and action. We…

lab-animal 2011
Chemico-biological interactions ·doi:10.1016/j.cbi.2010.12.012

The human aldo-keto reductases 1C1 and 1C3 (AKR1C1 and AKR1C3) are important 20-ketosteroid reductases in pre-receptor regulation of progesterone action. Both AKR1C1 and AKR1C3 convert progesterone to the less potent metabolite 20α-hydroxyp…

lab-animal 2011
Steroids ·doi:10.1016/j.steroids.2011.02.043

Dydrogesterone is widely used for menstrual disorders, endometriosis, threatened and habitual abortion and postmenopausal hormone replacement therapy. Although progestins have a promiscuous nature, dydrogesterone does not have clinically re…